Distalmotion Secures $70 Million to Scale Surgical Robot
The company plans to expand the adoption of its mobile DEXTER system within US ambulatory surgery centers.
Updated on Oct. 21, 2026 in Robotics
Live Poll
Do you support the shift of complex robotic surgery services into local outpatient surgery centers?
Distalmotion has secured a $70 million term loan facility from Perceptive Advisors to expand the presence of its DEXTER Robotic Surgery System in the United States. The mobile surgical robot is currently authorized for use in adult procedures including hysterectomies and hernia repairs.
Why it matters
This capital injection provides the resources for Distalmotion to scale its presence within US ambulatory surgery centers, a market segment that often lacks the infrastructure to host larger, permanent robotic platforms.
The DEXTER system utilizes a mobile architecture designed for integration into ambulatory surgery centers without room modifications. It employs single-use instruments to bypass the need for external sterile processing cycles required by many larger surgical robotics competitors.
The players
Distalmotion
A developer of mobile surgical robotics with headquarters in Lausanne and US operations in Cleveland.
Perceptive Advisors
An investment firm specializing in the life sciences and healthcare sectors.
The details
DEXTER functions as a mobile robot for minimally invasive surgery that allows surgeons to move between tables for different procedure types. Its primary design innovation is the integration of single-use components, which reduces the need for the specialized cleaning facilities typically found in hospital ORs. The system is specifically authorized for inguinal and ventral hernia repairs, cholecystectomies, and hysterectomies in adults aged 22 and older.
Timeline
October 21, 2026: Distalmotion announced the secured $70 million loan facility.
The Tech Race
Distalmotion competes in a crowded surgical robotics market where incumbents like Intuitive Surgical have long dominated the hospital-based sector. The DEXTER system aims to secure a niche in ambulatory surgery centers by prioritizing mobility over the fixed-base designs prevalent in the field.
Surgeons and administrators in US ambulatory surgery centers can expect increased availability of the DEXTER platform as the company executes its growth strategy. The system is specifically designed for environments that require flexible, non-permanent robotic integration for adult elective surgeries.
The takeaway
Distalmotion is betting that mobile platforms can unlock the high-volume ambulatory surgery center market. Watch for future clinical data or facility adoption rates in the US to see if this model successfully displaces established hospital-based surgical stacks.
Further reading
For more on the current state of surgical automation, see our section on Robotics.
More information
Find further details on the system capabilities and clinical applications at the Distalmotion corporate website.
Live Poll
Do you support the shift of complex robotic surgery services into local outpatient surgery centers?
